Loading patent…
AssigneeBeckman Coulter, Inc.
InventorsDiana B. Careaga, Robert T. Magari, Liliana M. Tejidor, Nicole Carpio
Estimating the term…
Embodiments of the present disclosure may allow for an efficient and accurate way or system to assess whether an individual has sepsis, including an individual who may exhibit symptoms or clinical criteria similar to inflammation. Embodiments include using a laboratory test that may be routinely ordered. Embodiments of the present invention may allow for the diagnosis of sepsis even when some cells show an abnormal size. Often, when white blood cells show a likelihood of an abnormal size, a “blast flag” in a system is triggered to warn a user that the sample may warrant further analysis. Unexpectedly, the diagnosis of sepsis status using standard deviation of monocyte volume may be more accurate when considering whether a blast flag has been triggered. Based on the sepsis status, treatment may be started quickly, thereby preventing complications, including organ failure and death, of not treating sepsis fast enough.
An automated method for evaluating a sepsis status associated with a blood sample obtained from an individual, the method comprising, through execution of instructions stored on a non-transitory computer readable medium by a processor:
Dependencies are inferred from the claim text.